Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is based in New Taipei City, Taiwan.
Metrics to compare | 1762 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1762PeersSector | |
---|---|---|---|---|
P/E Ratio | 114.8x | 17.6x | −0.5x | |
PEG Ratio | −1.53 | 0.13 | 0.00 | |
Price/Book | 0.7x | 2.9x | 2.6x | |
Price / LTM Sales | 1.8x | 3.0x | 3.3x | |
Upside (Analyst Target) | - | 2.7% | 43.5% | |
Fair Value Upside | Unlock | 24.1% | 6.8% | Unlock |